Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Two-treatment,Randomized, Controlled, Multicenter Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Expanded Allogeneic Adipose Tissue Adult Mesenchymal Stromal Cells in Critically Ill Patients COVID-19

NCT04348461 is registered in ClinicalTrials.gov with Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz as lead sponsor.

NCT NCT04348461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04348461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Two-treatment,Randomized, Controlled, Multicenter Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Expanded Allogeneic Adipose Tissue Adult Mesenchymal Stromal Cells in Critically Ill Patients COVID-19
Lead sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Phase
Phase 2
Overall status
Suspended
Start date
May 6, 2020
Completion date
September 30, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid, respiratory distress syndrome